Accuray Incorporated (ARAY)

The total asset value of Accuray Incorporated (ARAY) stood at $ 680 Mln as on 31-Dec-24

The share price of Accuray Incorporated (ARAY) is $1.48 (NASDAQ) as of 17-Apr-2025 16:19 EDT. Accuray Incorporated (ARAY) has given a return of -23.22% in the last 3 years.

Accuray Incorporated (ARAY) has a market capitalisation of $ 150 Mln as on 17-Apr-2025. As per Value Research classification, it is a Small Cap company.

The P/B ratio of Accuray Incorporated (ARAY) is 3.22 times as on 17-Apr-2025, a 2% discount to its peers’ median range of 3.27 times.

Since, TTM earnings of Accuray Incorporated (ARAY) is negative, P/E ratio is not available.

Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Accuray Incorporated (ARAY) and enter the required number of quantities and click on buy to purchase the shares of Accuray Incorporated (ARAY).

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin. Address: 1240 Deming Way, Madison, WI, United States, 53717-1954

The CEO & director of Ms. Suzanne Winter M.B.A.. is Accuray Incorporated (ARAY), and CFO & Sr. VP is Ms. Suzanne Winter M.B.A..

There is no promoter pledging in Accuray Incorporated (ARAY).

Some of the close peers are:

No, TTM profit after tax of Accuray Incorporated (ARAY) was $0 Mln.